INR 12.21
(-0.41%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 7.18 Million INR | -89.11% |
2022 | 66.03 Million INR | 64.12% |
2021 | 40.23 Million INR | 284.58% |
2020 | 10.46 Million INR | 3091.33% |
2019 | 327.84 Thousand INR | -95.41% |
2018 | 7.13 Million INR | -10.54% |
2017 | 7.97 Million INR | 20.17% |
2016 | 6.63 Million INR | 2290.43% |
2015 | -303 Thousand INR | -118.76% |
2014 | 1.61 Million INR | -46.26% |
2013 | 3 Million INR | -49.92% |
2012 | 6 Million INR | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | 16.99 Million INR | 136.28% |
2023 Q2 | 17.03 Million INR | 7.42% |
2023 Q3 | 21.11 Million INR | 23.97% |
2023 Q4 | -46.82 Million INR | -321.72% |
2023 FY | 7.18 Million INR | -89.11% |
2023 Q1 | 15.85 Million INR | 263.66% |
2022 Q1 | 15.11 Million INR | 645.05% |
2022 Q2 | 19.94 Million INR | 31.95% |
2022 Q3 | 26.62 Million INR | 33.49% |
2022 Q4 | 4.36 Million INR | -83.62% |
2022 FY | 66.03 Million INR | 64.12% |
2021 FY | 40.23 Million INR | 284.58% |
2021 Q4 | 2.02 Million INR | -87.38% |
2021 Q3 | 16.07 Million INR | 14.68% |
2021 Q2 | 14.01 Million INR | 72.62% |
2021 Q1 | 8.11 Million INR | 156.05% |
2020 FY | 10.46 Million INR | 3091.33% |
2020 Q4 | -14.48 Million INR | -184.14% |
2020 Q3 | 17.21 Million INR | 123.37% |
2020 Q2 | 7.7 Million INR | 23254.55% |
2020 Q1 | 33 Thousand INR | 100.4% |
2019 Q1 | 59 Thousand INR | -97.07% |
2019 FY | 327.84 Thousand INR | -95.41% |
2019 Q4 | -8.16 Million INR | -434.21% |
2019 Q3 | 2.44 Million INR | -57.76% |
2019 Q2 | 5.78 Million INR | 9706.78% |
2018 Q3 | 2.01 Million INR | 29.66% |
2018 Q2 | 1.55 Million INR | 0.0% |
2018 Q1 | 1.55 Million INR | -46.53% |
2018 FY | 7.13 Million INR | -10.54% |
2018 Q4 | 2.01 Million INR | 0.0% |
2017 Q3 | 2.9 Million INR | 168.4% |
2017 Q1 | 1.08 Million INR | 0.0% |
2017 Q2 | 1.08 Million INR | 0.0% |
2017 Q4 | 2.9 Million INR | 0.0% |
2017 FY | 7.97 Million INR | 20.17% |
2016 FY | 6.63 Million INR | 2290.43% |
2015 FY | -303 Thousand INR | -118.76% |
2014 FY | 1.61 Million INR | -46.26% |
2013 FY | 3 Million INR | -49.92% |
2012 FY | 6 Million INR | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Alembic Pharmaceuticals Limited | 6.15 Billion INR | 99.883% |
Hester Biosciences Limited | 188.89 Million INR | 96.194% |
Aarti Drugs Limited | 1.71 Billion INR | 99.581% |
Aarti Pharmalabs Limited | 2.16 Billion INR | 99.669% |
Albert David Limited | 754.2 Million INR | 99.047% |
Alembic Limited | 2.68 Billion INR | 99.732% |
Alkem Laboratories Limited | 17.95 Billion INR | 99.96% |
Bafna Pharmaceuticals Limited | 73.47 Million INR | 90.216% |
Bajaj HealthCare Limited | -837.93 Million INR | 100.858% |
Biofil Chemicals and Pharmaceuticals Limited | 7.09 Million INR | -1.368% |
Brooks Laboratories Limited | -195.91 Million INR | 103.669% |
Eris Lifesciences Limited | 3.91 Billion INR | 99.817% |
FDC Limited | 3.05 Billion INR | 99.764% |
Glenmark Life Sciences Limited | 4.7 Billion INR | 99.847% |
Gufic Biosciences Limited | 861.35 Million INR | 99.165% |
Hikal Limited | 696 Million INR | 98.967% |
Ind-Swift Limited | 142.31 Million INR | 94.948% |
Innova Captab Limited | 943.45 Million INR | 99.238% |
IOL Chemicals and Pharmaceuticals Limited | 1.34 Billion INR | 99.465% |
Jagsonpal Pharmaceuticals Limited | 224.63 Million INR | 96.8% |
Jubilant Pharmova Limited | 771 Million INR | 99.068% |
Lincoln Pharmaceuticals Limited | 933.04 Million INR | 99.23% |
Lupin Limited | 19.14 Billion INR | 99.962% |
Mangalam Drugs & Organics Limited | -90.71 Million INR | 107.925% |
Medico Remedies Limited | 82.9 Million INR | 91.329% |
Morepen Laboratories Limited | 961.59 Million INR | 99.252% |
Nectar Lifesciences Limited | 49.95 Million INR | 85.608% |
Orchid Pharma Limited | 921.66 Million INR | 99.22% |
Procter & Gamble Health Limited | 2 Billion INR | 99.642% |
RPG Life Sciences Limited | 876.6 Million INR | 99.18% |
Kilitch Drugs (India) Limited | 146.01 Million INR | 95.076% |
Sigachi Industries Limited | 571.8 Million INR | 98.743% |
Solara Active Pharma Sciences Limited | -5.67 Billion INR | 100.127% |
Suven Pharmaceuticals Limited | 3 Billion INR | 99.761% |
Themis Medicare Limited | 435.23 Million INR | 98.348% |
Unichem Laboratories Limited | -704.74 Million INR | 101.02% |
Wanbury Limited | 559.56 Million INR | 98.715% |
Windlas Biotech Limited | 581.87 Million INR | 98.765% |
ZIM Laboratories Limited | 172.46 Million INR | 95.832% |
Ind-Swift Laboratories Limited | 4.2 Billion INR | 99.829% |
Ipca Laboratories Limited | 5.47 Billion INR | 99.869% |
Sun Pharmaceutical Industries Limited | 95.76 Billion INR | 99.992% |
Venus Remedies Limited | 284.9 Million INR | 97.477% |
Sakar Healthcare Limited | 116.7 Million INR | 93.84% |
Aurobindo Pharma Limited | 31.72 Billion INR | 99.977% |
Divi's Laboratories Limited | 16 Billion INR | 99.955% |
AstraZeneca Pharma India Limited | 1.61 Billion INR | 99.555% |
Mankind Pharma Limited | 19.12 Billion INR | 99.962% |
Sequent Scientific Limited | -358.69 Million INR | 102.004% |
Laurus Labs Limited | 1.6 Billion INR | 99.552% |
Neuland Laboratories Limited | 3 Billion INR | 99.76% |
J. B. Chemicals & Pharmaceuticals Limited | 5.52 Billion INR | 99.87% |
Glenmark Pharmaceuticals Limited | -15.01 Billion INR | 100.048% |
Zydus Lifesciences Limited | 38.59 Billion INR | 99.981% |
Amrutanjan Health Care Limited | 449.72 Million INR | 98.401% |
Wockhardt Limited | -4.63 Billion INR | 100.155% |
Bal Pharma Limited | 73.92 Million INR | 90.275% |
Dr. Reddy's Laboratories Limited | 55.68 Billion INR | 99.987% |
Bliss GVS Pharma Limited | 754.54 Million INR | 99.047% |
Par Drugs and Chemicals Limited | 145.01 Million INR | 95.042% |
Caplin Point Laboratories Limited | 4.57 Billion INR | 99.843% |
Shilpa Medicare Limited | 318.74 Million INR | 97.745% |
Valiant Laboratories Limited | 3.19 Million INR | -124.937% |
Ajanta Pharma Limited | 8.16 Billion INR | 99.912% |
Aarey Drugs & Pharmaceuticals Limited | 46.83 Million INR | 84.651% |
Granules India Limited | 4.05 Billion INR | 99.823% |
Medicamen Biotech Limited | 109.31 Million INR | 93.423% |
Syncom Formulations (India) Limited | 253.14 Million INR | 97.16% |
Piramal Enterprises Limited | -16.83 Billion INR | 100.043% |
Torrent Pharmaceuticals Limited | 16.56 Billion INR | 99.957% |
NATCO Pharma Limited | 13.88 Billion INR | 99.948% |
Suven Life Sciences Limited | -1.05 Billion INR | 100.684% |
Krebs Biochemicals & Industries Limited | -197.28 Million INR | 103.644% |
Strides Pharma Science Limited | -706.14 Million INR | 101.018% |
Indoco Remedies Limited | 984.6 Million INR | 99.27% |
Alpa Laboratories Limited | 167.76 Million INR | 95.715% |
Lasa Supergenerics Limited | -217.3 Million INR | 103.308% |
Sun Pharma Advanced Research Company Limited | -3.87 Billion INR | 100.186% |